URGN logo

UroGen Pharma Ltd. (URGN)

Profile

Full Name

UroGen Pharma Ltd.

Ticker

NASDAQ: URGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 4, 2017

Indexes

Not included

Website

https://www.urogen.com

Employees

234

Key Details

Price

$19.11(-7.64%)

Market cap

$881.11M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$90.40M(+9.29% YoY)

Annual EPS

-$2.96(+16.62% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $19.11
    URGN price is $19.11

    30-Day Relative Volume

    1.44
    URGN 30-day relative volume is 1.44

    Price Performance

    Price Most recent change

    -7.64%
    URGN price was down -7.64% on Sep 10, 2025

    Price YTD change

    +79.44%
    URGN price is up +79.44% since January 1st

    Price 1-year change

    +38.38%
    URGN price is up +38.38% year-on-year

    Price 3-year change

    +142.21%
    URGN price is up +142.21% over the past 3 years

    Price Range

    Price All-time high

    $69.57
    URGN price is currently -72.53% below its historical high of $69.57

    Price 3-year low

    $3.42
    URGN price is currently +458.77% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $881.11M
    URGN market capitalization is $881.11 million

    Market cap 3-year change

    +391.08%
    URGN market capitalization is up +391.08% over the past 3 years

    Market cap All-time high

    $1.01B
    URGN market capitalization is currently -12.84% below its historical high of $1.01 billion

    Market cap sector rank

    71.01%
    URGN market capitalization is higher than 71.01% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +9.48%
    URGN shares outstanding is up +9.48% year-on-year

    Shares Outstanding 3-Year Change

    +102.75%
    URGN shares outstanding is up +102.75% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.15
    URGN beta is 1.15

    200-day SMA

    $12.26
    URGN price is currently +55.91% above its 200-day simple moving average

    50-day SMA

    $17.83
    URGN price is currently +7.16% above its 50-day simple moving average

    RSI

    50.42
    URGN 14-day relative strength index is 50.42

    Volume

    1.44
    URGN 30-day relative volume is 1.44

    ATR

    $1.27
    URGN average true range is $1.27

    10-day Historical Volatility

    86.00%
    URGN 10-day historical volatility is 86.00%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $90.40M
    URGN annual revenue is $90.40 million

    Revenue Analysts estimate

    $123.68M
    URGN annual revenue is currently -26.91% lower than the consensus analysts' forecast

    Revenue 1-year change

    +9.29%
    URGN annual revenue is up +9.29% year-on-year

    Revenue Sector rank

    67.78%
    URGN annual revenue is higher than 67.78% of companies in Healthcare sector

    EPS

    EPS

    -$2.96
    URGN annual earnings per share is -$2.96

    EPS Analysts estimate

    -$2.99
    URGN annual earnings per share is currently -1.10% lower than the consensus analysts' forecast

    EPS 1-year change

    +16.62%
    URGN annual earnings per share is up +16.62% year-on-year

    EPS Sector rank

    29.52%
    URGN annual earnings per share is higher than 29.52% of companies in Healthcare sector

    Profit

    Gross profit

    $81.52M
    URGN annual gross profit is $81.52 million

    Gross margin

    90.18%
    URGN annual gross profit margin is 90.18%

    Operating profit

    -$96.78M
    URGN annual operating income is -$96.78 million

    Operating margin

    -107.06%
    URGN annual operating profit margin is -107.06%

    Net income

    -$126.87M
    URGN annual net profit is -$126.87 million

    Net margin

    -140.35%
    URGN annual net profit margin is -140.35%

    Expenses

    Total expenses

    $187.18M
    URGN annual total expenses is $187.18 million

    Operating expenses

    $178.30M
    URGN annual total operating expenses is $178.30 million

    Cost of goods sold

    $8.88M
    URGN annual cost of goods sold is $8.88 million

    Selling, general & administrative expenses

    $121.15M
    URGN annual SGA is $121.15 million

    Depreciation and amortization

    $1.19M
    URGN annual depreciation & amortization is $1.19 million

    Interest expense

    $0.00
    URGN annual interest expense is $0.00

    Income tax

    $2.83M
    URGN annual income tax is $2.83 million

    EBIT & EBITDA

    EBIT

    -$111.52M
    URGN annual earnings before interest & taxes is -$111.52 million

    EBITDA

    -$110.33M
    URGN annual EBITDA is -$110.33 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $285.71M
    URGN annual total assets is $285.71 million

    Non current assets

    $9.58M
    URGN annual long term assets is $9.58 million

    Current assets

    $276.13M
    URGN annual total current assets is $276.13 million

    Cash and cash equivalents

    $171.99M
    URGN annual cash & cash equivalents is $171.99 million

    Accounts receivable

    $20.30M
    URGN annual accounts receivable is $20.30 million

    Inventory

    $9.23M
    URGN annual inventory is $9.23 million

    Liabilities

    Total liabilities

    $294.51M
    URGN annual total liabilities is $294.51 million

    Long term liabilities

    $248.56M
    URGN annual total long term liabilities is $248.56 million

    Current liabilities

    $45.95M
    URGN annual total current liabilities is $45.95 million

    Accounts payable

    $10.93M
    URGN annual accounts payable is $10.93 million

    Debt

    Total debt

    $124.92M
    URGN annual total debt is $124.92 million

    Total debt 1-year change

    +24.65%
    URGN annual total debt is up +24.65% year-on-year

    Long term debt

    $123.39M
    URGN annual long term debt is $123.39 million

    Short term debt

    $1.53M
    URGN annual short term debt is $1.53 million

    Equity & Capital

    Shareholders equity

    -$8.80M
    URGN annual stockholders equity is -$8.80 million

    Book value

    -$8.80M
    URGN annual book value is -$8.80 million

    Retained earnings

    -$806.22M
    URGN annual retained earnings is -$806.22 million

    Working capital

    $230.19M
    URGN annual working capital is $230.19 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$96.77M
    URGN annual cash flow from operations is -$96.77 million

    Cash from operations 1-year change

    -26.7%
    URGN annual cash flow from operations is down -26.7% year-on-year

    Cash from investing

    -$20.61M
    URGN annual cash flow from investing activities is -$20.61 million

    Cash from investing 1-year change

    -2062.96%
    URGN annual cash flow from investing activities is down -2062.96% year-on-year

    Cash from financing

    $194.62M
    URGN annual cash flow from financing activities is $194.62 million

    Cash from financing 1-year change

    +66.44%
    URGN annual cash flow from financing activities is up +66.44% year-on-year

    CAPEX

    CAPEX

    $295.00K
    URGN annual capital expenditures is $295.00 thousand

    CAPEX 1-year change

    +52.06%
    URGN annual capital expenditures is up +52.06% year-on-year

    Free Cash Flow

    Free cash flow

    -$97.06M
    URGN annual free cash flow is -$97.06 million

    Free cash flow 1-year change

    -26.76%
    URGN annual free cash flow is down -26.76% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    90.18%
    URGN annual gross profit margin is 90.18%

    Operating margin

    -107.06%
    URGN annual operating profit margin is -107.06%

    Net margin

    -140.35%
    URGN annual net profit margin is -140.35%

    ROA & ROE

    ROA

    -54.68%
    URGN annual return on assets is -54.68%

    ROE

    1441.26%
    URGN annual return on equity is 1441.26%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    URGN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    URGN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -9.44
    URGN price to book ratio is -9.44

    PB ratio Sector rank

    4.47%
    URGN price to book ratio is higher than 4.47% of companies in Healthcare sector

    PS Ratio

    PS ratio

    9.35
    URGN price to sales ratio is 9.35

    PS ratio Sector rank

    72.21%
    URGN price to sales ratio is higher than 72.21% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $850.55M
    URGN enterprise value is $850.55 million

    Enterprise value Sector rank

    71.94%
    URGN enterprise value is higher than 71.94% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -6.98
    URGN EV/EBITDA is -6.98

    EV/EBITDA Sector rank

    17.99%
    URGN EV/EBITDA is higher than 17.99% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    6.01
    URGN annual current ratio is 6.01

    Quick ratio

    5.81
    URGN annual quick ratio is 5.81

    Leverage

    Debt to equity

    -14.19
    URGN annual debt to equity ratio is -14.19

    Interest coverage ratio

    -
    URGN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    1
    URGN piotroski f-score is 1

    Altman Z-Score

    -2.16
    URGN altman z-score is -2.16

    Analyst ratings

    Recent major analysts updates

    Aug 19, 25 Piper Sandler
    Overweight
    Aug 11, 25 HC Wainwright & Co.
    Buy
    Aug 7, 25 D. Boral Capital
    Buy
    Aug 5, 25 D. Boral Capital
    Buy
    Jul 8, 25 HC Wainwright & Co.
    Buy
    Jul 7, 25 D. Boral Capital
    Buy
    Jun 16, 25 HC Wainwright & Co.
    Buy
    Jun 13, 25 Scotiabank
    Sector Outperform
    Jun 13, 25 Oppenheimer
    Outperform
    Jun 13, 25 Guggenheim
    Buy

    Institutional Ownership

    Screeners with URGN included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    • What is the ticker symbol for UroGen Pharma Ltd.?
    • Does UroGen Pharma Ltd. pay dividends?
    • What sector is UroGen Pharma Ltd. in?
    • What industry is UroGen Pharma Ltd. in?
    • What country is UroGen Pharma Ltd. based in?
    • When did UroGen Pharma Ltd. go public?
    • Is UroGen Pharma Ltd. in the S&P 500?
    • Is UroGen Pharma Ltd. in the NASDAQ 100?
    • Is UroGen Pharma Ltd. in the Dow Jones?
    • When was UroGen Pharma Ltd.'s last earnings report?
    • When does UroGen Pharma Ltd. report earnings?

    What is the ticker symbol for UroGen Pharma Ltd.?

    The ticker symbol for UroGen Pharma Ltd. is NASDAQ:URGN

    Does UroGen Pharma Ltd. pay dividends?

    No, UroGen Pharma Ltd. does not pay dividends

    What sector is UroGen Pharma Ltd. in?

    UroGen Pharma Ltd. is in the Healthcare sector

    What industry is UroGen Pharma Ltd. in?

    UroGen Pharma Ltd. is in the Biotechnology industry

    What country is UroGen Pharma Ltd. based in?

    UroGen Pharma Ltd. is headquartered in United States

    When did UroGen Pharma Ltd. go public?

    UroGen Pharma Ltd.'s initial public offering (IPO) was on May 4, 2017

    Is UroGen Pharma Ltd. in the S&P 500?

    No, UroGen Pharma Ltd. is not included in the S&P 500 index

    Is UroGen Pharma Ltd. in the NASDAQ 100?

    No, UroGen Pharma Ltd. is not included in the NASDAQ 100 index

    Is UroGen Pharma Ltd. in the Dow Jones?

    No, UroGen Pharma Ltd. is not included in the Dow Jones index

    When was UroGen Pharma Ltd.'s last earnings report?

    UroGen Pharma Ltd.'s most recent earnings report was on August 7, 2025

    When does UroGen Pharma Ltd. report earnings?

    The next expected earnings date for UroGen Pharma Ltd. is November 6, 2025
    On this page